Retrieve Medical Holdings, Inc. financial data

Symbol
RMHI on OTC
Location
376 Main Street, Suite 100, Bedminster, NJ
State of incorporation
NV
Fiscal year end
September 30
Former names
PEAK PHARMACEUTICALS, INC. (to 3/21/2023), CANNABIS THERAPY CORP. (to 12/29/2014), FRAC WATER SYSTEMS, INC. (to 3/20/2014), SURF A MOVIE SOLUTIONS INC (to 7/29/2013)
Latest financial report
10-Q - Q4 2022 - Feb 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -128 % -332%
Return On Assets -159 % -54.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.4M shares
Common Stock, Shares, Outstanding 78.4M shares 0%
Entity Public Float 5.08M USD -43.2%
Common Stock, Value, Issued 7.84K USD 0%
Weighted Average Number of Shares Outstanding, Diluted 82M shares

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 222K USD +91.4%
Operating Income (Loss) -222K USD -91.4%
Net Income (Loss) Attributable to Parent -218K USD -70.1%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 102K USD -46.9%
Accounts Payable, Current 307K USD +55.7%
Accrued Liabilities, Current 126K USD +71.5%
Liabilities 706K USD +22%
Retained Earnings (Accumulated Deficit) -5.47M USD -4.15%
Stockholders' Equity Attributable to Parent -603K USD -56.5%
Liabilities and Equity 102K USD -46.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.9K USD +29.2%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 78.4M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30.9K USD +58%
Deferred Tax Assets, Valuation Allowance 343K USD +13.6%
Deferred Tax Assets, Gross 343K USD +13.6%
Deferred Tax Assets, Operating Loss Carryforwards 343K USD +13.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Additional Paid in Capital 4.86M USD 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 25.1K USD +48.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%